SR biotek Inc. (XKON:270210)
South Korea
· Delayed Price · Currency is KRW
29,800
-2,550 (-7.88%)
At close: Aug 14, 2025, 3:30 PM KST
SR biotek Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2016 | FY 2015 |
| Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
| Net Income | -76.98 | 461.08 |
| Depreciation & Amortization | 249.35 | 189.85 |
| Loss (Gain) From Sale of Assets | - | -78.19 |
| Provision & Write-off of Bad Debts | 2.07 | - |
| Other Operating Activities | 61.08 | 62.17 |
| Change in Accounts Receivable | -27.09 | 11.7 |
| Change in Inventory | 53.57 | - |
| Change in Accounts Payable | -12.02 | 34.36 |
| Change in Income Taxes | -4.46 | 2.88 |
| Change in Other Net Operating Assets | -88.54 | -562.38 |
| Operating Cash Flow | 156.99 | 121.47 |
| Operating Cash Flow Growth | 29.24% | - |
| Capital Expenditures | -134.56 | -1,653 |
| Sale of Property, Plant & Equipment | - | 307.7 |
| Sale (Purchase) of Intangibles | -0.39 | - |
| Sale (Purchase) of Real Estate | - | -247.72 |
| Investment in Securities | -100.6 | -0.6 |
| Other Investing Activities | 3.28 | 12.32 |
| Investing Cash Flow | -241.48 | -1,581 |
| Long-Term Debt Issued | - | 1,749 |
| Long-Term Debt Repaid | -120.29 | -238.39 |
| Net Debt Issued (Repaid) | -120.29 | 1,511 |
| Financing Cash Flow | -120.29 | 1,511 |
| Miscellaneous Cash Flow Adjustments | - | -0 |
| Net Cash Flow | -204.78 | 50.95 |
| Free Cash Flow | 22.43 | -1,531 |
| Free Cash Flow Margin | 1.38% | -81.61% |
| Free Cash Flow Per Share | 560.53 | -38285.18 |
| Levered Free Cash Flow | 48.56 | - |
| Unlevered Free Cash Flow | 80.56 | - |
| Change in Working Capital | -78.54 | -513.44 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.